ENHANCED GENOMICS LIMITED

Company number 12423696 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

What it does

The principal activity of the company is Research and experimental development on biotechnology

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2020-01-24
Employees
28 (2024 accounts · was 21 in 2023)
Registered office
Enhanced Genomics St John's Innovation Centre, Cowley Road, Cambridge, United Kingdom, CB4 0WS
Postcode
CB4 0WS
Capital
6 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2024-12-31
Next due by
2026-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-02-03
Next due by
2027-02-17
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 5 current · 14 resigned

Appointed 2025-07-18
PARKWALK ADVISORS LTD Corporate Director
Appointed 2022-08-25
DIRECTOR Appointed 2020-01-24
DIRECTOR Appointed 2020-01-24
DIRECTOR Appointed 2020-01-24

View all officers and resignations →

Group structure

Controlled by BGF INVESTMENT MANAGEMENT LIMITED — since 2025-08-28

From persons-with-significant-control filings on the public register.

Licensed visa sponsor

Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).

Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.

Data protection registration

Registered with the ICO as a data protection fee payer — ZB993204 (Tier 1), registered since 2025.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Contact details

Website
enhancedgenomics.com
Phone
+44 1223942520

Enhanced Genomics is redefining how medicines are discovered by revealing the causal biology behind genetic variation. Our integrated 3D multi-omics platform enables the rapid identification of high-confidence therapeutic targets for common diseases.

Previous company names

NameDate changed
ENHANC3D GENOMICS LTD2025-09-03

At this address

Among the biggest employers

of 157 similar companies in CB, with 28 staff.

The class of 2020

41%

of the 595 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →